ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,876Medicare Part D Prescriptions Filled, Including Refills

Rank: 362 out of 7188

$528K Total Retail Price of All Prescriptions

Rank: 659 out of 7188

536 Patients Receiving at Least One Drug in Part D
59% Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in California
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

5% of this provider’s 536 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

14% of this provider’s 536 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in California
METOPROLOL TARTRATE 514 222 100 1 13
LEVOTHYROXINE SODIUM 438 193 90 2 3
AMLODIPINE BESYLATE 349 197 79 3 5
SIMVASTATIN 343 161 76 4 1
OMEPRAZOLE 341 161 72 5 6
ATORVASTATIN CALCIUM 326 191 72 6 8
METFORMIN HCL 244 124 61 7 7
FUROSEMIDE 242 162 61 8 12
FAMOTIDINE* 235 151 59 9 41
PANTOPRAZOLE SODIUM 228 167 67 10 29
LISINOPRIL 228 99 74 10 2
WARFARIN SODIUM 221 188 25 12 24
HYDROCODONE-ACETAMINOPHEN 203 103 72 S3 13 4
NAMENDA 168 138 20 14 44
CARVEDILOL 166 153 42 15 26
IPRATROPIUM-ALBUTEROL 165 138 21 16 200
GABAPENTIN 150 76 45 17 14
LEVETIRACETAM 130 44 22 18 119
TAMSULOSIN HCL 126 84 30 19 22
CLOPIDOGREL 115 72 30 20 28
GEMFIBROZIL 109 14 13 21 92
DIOVAN 108 83 18 22 33
TRAMADOL HCL 106 38 35 23 27
POTASSIUM CHLORIDE 103 66 29 24 34
BENZTROPINE MESYLATE 101 22 20 R 25 171
MIRTAZAPINE 101 63 27 25 77
DONEPEZIL HCL 100 79 23 27 36
SERTRALINE HCL 99 63 21 28 40
OXYBUTYNIN CHLORIDE 97 32 18 29 121
LOSARTAN POTASSIUM 96 58 20 30 11
BENAZEPRIL HCL 96 30 19 30 18
JANUVIA 94 54 20 32 42
QUETIAPINE FUMARATE 92 27 24 A 33 81
HEPARIN SODIUM 90 67 20 34 319
ZOLPIDEM TARTRATE 86 32 34 35 17
METOPROLOL SUCCINATE 86 38 17 35 21
RISPERIDONE 86 34 22 A 35 93
LANTUS 86 63 34 35 58
GLIPIZIDE 80 43 13 39 20
TRAZODONE HCL 77 26 21 40 43
SPIRONOLACTONE 77 31 14 40 105
CARBIDOPA-LEVODOPA 71 58 16 42 133
DIVALPROEX SODIUM 69 17 16 43 107
ADVAIR DISKUS 67 34 19 44 49
OXYBUTYNIN CHLORIDE ER 66 <11 <11 45 156
LORAZEPAM 63 39 34 B 46 25
IBUPROFEN 62 16 26 47 35
NOVOLOG 60 46 28 48 148
FLUOXETINE HCL 58 <11 <11 49 51
ALLOPURINOL 57 <11 <11 50 37
NYSTATIN 57 37 19 50 182
GENERLAC 55 <11 <11 52 326
SPIRIVA 55 32 18 52 68
MONTELUKAST SODIUM 55 43 11 52 53
CLONIDINE HCL 53 21 18 55 60
OLANZAPINE 52 11 14 A 56 135
HUMALOG 51 40 26 57 219
ENOXAPARIN SODIUM 50 <11 <11 58 262
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 2, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.